Loading clinical trials...
Loading clinical trials...
Sodium Channel Mutations (SCN9A, SCN10A) in the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES)
The goal of this observational study is to learn about sodium channel (Nav) mutations in patients with the Anterior Cutaneous Nerve Entrapment Syndrome (ACNES). This study will give more insight into the pathophysiology of ACNES, which is still largely unknown. The primary objective is to determine if there are mutations of Nav1.7 and Nav1.8 in patients with ACNES. Therefore, one blood sample will be drawn, in which the mutations will be analyzed.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Maxima Medical Center
Veldhoven, Netherlands
Start Date
October 3, 2023
Primary Completion Date
June 1, 2024
Completion Date
December 1, 2024
Last Updated
October 30, 2023
50
ESTIMATED participants
Sodium channel mutation
OTHER
Lead Sponsor
Maxima Medical Center
NCT06929598
NCT06387706
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07468591